HOME >> BIOLOGY >> NEWS
Computers have had dramatic impact on chemistry

    There is one thing stronger than all the armies in the world, and that is an idea whose time has come. -Victor Hugo
(Blacksburg, Va., Aug. 23, 1999) -- This year marks the 25th anniversary of the ACS Division of Computers in Chemistry. The division will celebrate the event, during the 218th American Chemical Society National Meeting in New Orleans, Aug. 22-26, with a symposium that will look at the past and future of computer use in chemistry. The program will feature presenters who have had an impact in that period, including Raymond E. Dessy, professor of chemistry at Virginia Tech, author of the "WebWorks" column in Analytical Chemistry, and recipient of the first ACS National Award for Computers in Chemistry.

Dessy will talk about the evolution of computer use in the initial stages of research -- to record a scientist's notes and data, for 'mining' information in institutional databases, and for large scale testing of compounds during the advanced stages of new drug discovery. He will also explore mistaken predictions, the challenges of human adaptation, and technology on the horizon. His presentation, "Some call the world a dreary place" (Comp 30), is Monday, Aug. 23, at 10:30 a.m. in Convention Center room 225-227.

"It is a fascinating period," says Dessy. "In 25 years, we have gone from computers with 4K of memory -- which wouldn't hold today's screen savers -- to the ability to process huge volumes of data."

In the 1970s, computing centers were not addressing the needs of chemistry, he recalls. "Industrial scientists were champing at the 'byte' because they knew computer power was central to their jobs. When PCs were introduced, many scientists realized they were the solution for the lab. But most scientists didn't know how to use PCs, let alone how to interface with lab equipment." Between 1972 and 1992, Virginia Tech and the American Chemical Society provided week-long courses for 5,000 scientists, giving t
'"/>

Contact: Raymond Dessy
rdessy@chemserver.chem.vt.edu
540-231-5842
Virginia Tech
23-Aug-1999


Page: 1 2 3 4 5 6

Related biology news :

1. 20 May AAAS lecture: Computers that Respond to Human Emotion
2. Computers help veterinarians diagnosis pets with rare diseases
3. Computers to help doctors identify rare diseases
4. Computers use Darwinian model to evolve fuel additives
5. Molecular Computers? Munich/UD Researchers Report First Glimpse Of Artificial Molecule In Action
6. Computers, GIS Help Prevent Ground Water Contamination
7. Clusters, Computers And The Human Brain
8. Genetic discovery could dramatically reduce need for liver transplants in children
9. Combination therapy dramatically improves function after spinal cord injury in rats
10. Scientists develop new cloning technique that dramatically shortens the search for genes
11. Mastectomy dramatically reduces breast cancer risk among women with BRCA1/2 mutations

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Computers have had dramatic impact chemistry

(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: